A schizophrenia medication previously required daily has now been developed as a once-monthly subcutaneous (SC) injection. On October 9, the U.S. Food and Drug Administration (FDA) approved Israeli ...

Results from the global Phase 3 ALKIVIA study, the first registrational study investigating an FcRn blocker in autoimmune myositis, show ...

"The Kardashians" star said her daughter True, whom she shares with Tristan Thompson, had named the frozen embryo.

Registered sex offender Reginald Smith, who owns Family Cash 4 Gold, allegedly dragged his employee into a back room while ...

Danish drugmaker Novo Nordisk forecasts 15-20% annual growth for GLP-1 drugs in India amid rising competition, introducing ...

A 3-2-1 countdown sends two classic Porsche 911 Turbos racing from a roll down Utah Motorsports Park’s front straight, the ...

The Brewer Foundation announces record-breaking participation in the 2026–27 International Public Policy Forum (IPPF), marking a historic start to the competition's 26th year. A record 506 teams from ...

Novo Nordisk is pressing ahead with obesity and cardiometabolic drug development, including CagriSema regulatory submissions ...

Gilead Sciences has notched a phase 2 win in ulcerative colitis (UC), with its once-daily pill emvistegrast outperforming ...

Resubmission includes Chemistry, Manufacturing, and Controls (CMC) data from new drug product (DP) manufacturing vendor ...

Walk through the bustling concourses of the Indiana Convention Center in downtown Indianapolis this week, and you’ll witness a sea of blue corduroy jackets—more than 70,000 strong! While the National ...

Ghuge inventions span physical-activity oral airway technology, biometric tracking, controllers, a longer-term vision ...